Bone-anchored hearing implant mean less invasive surgical procedure

CENTENNIAL, Colorado, USA – Cochlear Americas has announced the introduction of its Cochlear Baha BIA400 series of bone-anchored hearing solutions, featuring a unique abutment surface technology. Its hydroxyapatite layer enables a tight adherence between the soft tissue and the abutment. The new technology is designed to minimise the need for soft tissue removal and to simplify surgery.

Because of the new technology, the surgical procedure becomes less invasive and soft tissue disruption can be minimised. Since the soft tissue will be left intact, surgery time may be significantly shorter, healing time may be faster, and there may be an increased likelihood of normal post-operative skin sensation around the implant site.

"As the first bone conduction implant company, we continue to innovate our solutions to better meet the needs of our recipients. We see the introduction of the BIA400 as a natural step in our continuous effort to improve the outcomes for our users," said Anthony Manna, president of Cochlear Bone Anchored Solutions.

The BIA400 series is currently being introduced to the North American market through a controlled market release. The devices are expected to be widely available to clinicians by early 2013.